Authors: Koonsaeng, S Verschraegen, C Freedman, R Bossens, M Kudelka, A Kavanagh, J Sittisomwong, T DeClercq, E Snoeck, R

Citation: S. Koonsaeng et al., Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir, J MED VIROL, 64(2), 2001, pp. 195-198

Authors: DeClercq, E

Citation: E. Declercq, Novel compounds in preclinical/early clinical development for the treatment of HIV infections (vol 10, pg 255, 2000), REV MED VIR, 10(5), 2000, pp. 349-349

Authors: Smith, C Noordeen, SK DeClercq, E Grosset, JH Cartel, JL Colston, MJ Ji, BH

Citation: C. Smith et al., Chemoprophylaxis against leprosy: expectations and methodology of a trial - Discussion, LEPROSY REV, 71, 2000, pp. S40-S41

Authors: Dimmock, JR Kumar, P Nazarali, AJ Motaganahalli, NL Kowalchuk, TP Beazely, MA Quail, JW Oloo, EO Allen, TM Szydlowski, J DeClercq, E Balzarini, J

Citation: Jr. Dimmock et al., Cytotoxic 2,6-bis(arylidene)cyclohexanones and related compounds, EUR J MED C, 35(11), 2000, pp. 967-977

Authors: Pandeya, SN Sriram, D Nath, G DeClercq, E

Citation: Sn. Pandeya et al., Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff andMannich bases derived from isatin derivatives and N-[4-(4 '-chlorophenyl)thiazol-2-yl] thiosemicarbazide, EUR J PH SC, 9(1), 1999, pp. 25-31

Authors: Afouna, MI Mehta, SC Ghanem, AH Higuchi, WI Kern, ER DeClercq, E El-Shattaway, HH

Citation: Mi. Afouna et al., Influence of the treatment protocol upon the in vivo efficacy of cidofovir(HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice, J PHARM SCI, 88(5), 1999, pp. 530-534